Second US patent granted
Montreal / April 05, 2024 – NexPlasmaGen is pleased to announce that on February 6, 2024, the 2nd U.S. patent (US ...
05 April, 2024 No commentMontreal / April 05, 2024 – NexPlasmaGen is pleased to announce that on February 6, 2024, the 2nd U.S. patent (US ...
05 April, 2024 No commentNEXPLASMAGEN TO PRESENT AT SEED SHOWCASE 2022 NexPlasmaGen will pitch its business opportunity to investors! Montreal/De...
24 December, 2021 No commentNexPlasmaGen is proud to announce that the preclinical trials program led by Dr. Philip Wong at the Centre Hospitaller d...
03 November, 2021 No commentMontreal / October 06, 2023 – NexPlasmaGen received a financial support of $219,500 from Quebec’s Ministère ...
06 October, 2023 No commentNEXPLASMAGEN TO PRESENT AT THE 2023 OBIO INVESTMENT SUMMIT Canada’s Premier Health Science Investment Event! Montreal/Fe...
02 February, 2023 No commentMontreal / April 19, 2024 – NexPlasmaGen is honored to announce that it has won GHP magazine’s Best MedTech ...
19 April, 2024 No commentNexPlasmaGen Inc. is pleased to announce the completion of $795,000 in private and public investment from individuals, A...
01 July, 2018 No commentMontreal / July 4, 2022 NexPlasmaGen is a finalist for the ADRIQ Innovation Award 2022 in the category Innovation from P...
04 July, 2022 No comment